X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (77) 77
humans (76) 76
female (66) 66
male (65) 65
middle aged (55) 55
aged (47) 47
adult (42) 42
retrospective studies (38) 38
warfarin (34) 34
risk factors (32) 32
atrial fibrillation (30) 30
apixaban (27) 27
aged, 80 and over (25) 25
stroke (25) 25
anticoagulants (23) 23
care and treatment (23) 23
prevalence (22) 22
adolescent (21) 21
young adult (21) 21
cardiac & cardiovascular systems (20) 20
risk (20) 20
clinical neurology (19) 19
rivaroxaban (19) 19
treatment outcome (19) 19
costs (18) 18
medicine, general & internal (18) 18
analysis (17) 17
dabigatran (17) 17
pharmacology & pharmacy (17) 17
comorbidity (16) 16
patients (16) 16
anesthesiology (15) 15
cohort studies (15) 15
internal medicine (15) 15
drug therapy (14) 14
health care sciences & services (14) 14
pain (14) 14
therapy (14) 14
dosage and administration (13) 13
hemorrhage (13) 13
oral anticoagulants (13) 13
safety (13) 13
united states - epidemiology (13) 13
atrial fibrillation - drug therapy (12) 12
cardiac arrhythmia (12) 12
medicine (12) 12
mortality (12) 12
oncology (12) 12
peripheral vascular disease (12) 12
anticoagulants - therapeutic use (11) 11
medical care, cost of (11) 11
outcomes (11) 11
propensity score (11) 11
united states (11) 11
united-states (11) 11
cardiovascular (10) 10
efficacy (10) 10
health care costs (10) 10
hospitalization (10) 10
opioids (10) 10
original research (10) 10
population (10) 10
prevention (10) 10
stroke prevention (10) 10
care (9) 9
data bases (9) 9
medicare (9) 9
metaanalysis (9) 9
opioid abuse (9) 9
pharmacy (9) 9
pyrazoles - therapeutic use (9) 9
research (9) 9
stroke - prevention & control (9) 9
studies (9) 9
warfarin - therapeutic use (9) 9
adherence (8) 8
anticoagulants - administration & dosage (8) 8
disease (8) 8
double-blind method (8) 8
electronic health records (8) 8
fibrillation (8) 8
hemorrhage - chemically induced (8) 8
impact (8) 8
pyridones - therapeutic use (8) 8
severity of illness index (8) 8
time factors (8) 8
abuse (7) 7
databases, factual (7) 7
diagnosis (7) 7
drug abuse (7) 7
health aspects (7) 7
health care policy (7) 7
healthcare costs (7) 7
hospitalization - statistics & numerical data (7) 7
management (7) 7
medical care (7) 7
non-valvular atrial fibrillation (7) 7
opioid-related disorders - economics (7) 7
proportional hazards models (7) 7
research article (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. e12541 - e12541
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2018, Volume 36, Issue 15, pp. e13075 - e13075
Conference Proceeding
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 11/2016, Volume 116, Issue 5, pp. 975 - 986
In addition to warfarin, there are four non-vitamin K antagonist oral anticoagulants (NOACs) available for stroke prevention in non valvular atrial... 
Rivaroxaban | Warfarin | Dabigatran | Non-valvular atrial fibrillation | Major bleeding | Apixaban | EFFICACY | SAFETY | rivaroxaban | apixaban | ASPIRIN | warfarin | STROKE | major bleeding | ORAL ANTICOAGULANTS | dabigatran | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY
Journal Article
Journal Article
Value in Health, ISSN 1098-3015, 2017, Volume 20, Issue 6, pp. 752 - 761
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2018, Volume 13, Issue 11, pp. e0205989 - e0205989
Limited real-world data are available regarding the comparative safety of non-vitamin K antagonist oral anticoagulants (NOACs). The objective of this... 
MORTALITY | TRIALS | METAANALYSIS | THERAPY | EVENTS | STROKE PREVENTION | EFFICACY | WARFARIN | SAFETY | ORAL ANTICOAGULANTS | MULTIDISCIPLINARY SCIENCES | Dabigatran - administration & dosage | Anticoagulants - administration & dosage | Humans | Middle Aged | Male | Warfarin - administration & dosage | Rivaroxaban - administration & dosage | Inpatients | Pyridones - administration & dosage | Vitamin K - antagonists & inhibitors | Aged, 80 and over | Adult | Female | Atrial Fibrillation - pathology | Risk Assessment | Administration, Oral | Atrial Fibrillation - drug therapy | Proportional Hazards Models | Stroke - drug therapy | Hemorrhage - drug therapy | Pyrazoles - administration & dosage | Outpatients | Adolescent | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Aged | Cohort Studies | Stroke (Disease) | Complications and side effects | Usage | Atrial fibrillation | Anticoagulants (Medicine) | Hemorrhage | Health aspects | Risk factors | Heart | Cardiac arrhythmia | Initiators | Embolisms | Clinical trials | Cardiovascular disease | Bleeding | Data bases | Confidence intervals | Demographics | Health economics | Fibrillation | Employers | Population | Vitamin K | Anticoagulants | Health insurance | Stroke | Warfarin | Mortality | Hyperthyroidism | Health care policy | Hazards | Patients | Pharmacy | Index Medicus
Journal Article
Drug and Alcohol Dependence, ISSN 0376-8716, 2017, Volume 175, pp. 140 - 145
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2018, Volume 36, Issue 15, pp. e12575 - e12575
Conference Proceeding
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 11, pp. 312 - 312
  Conclusions: In the real-world setting after balancing patient characteristics, apixaban treatment is associated with significantly lower risk of major... 
Cardiovascular | Internal Medicine | CARDIAC & CARDIOVASCULAR SYSTEMS | Aged patients | Health care industry | Anticoagulants (Medicine) | Atrial fibrillation | Risk factors | Health services | Patients
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2018, Volume 71, Issue 11, pp. A2042 - A2042
Multivariable generalized linear models were carried out to compare hospital LOS and cost, while controlling for key differences in patient and hospital... 
CARDIAC & CARDIOVASCULAR SYSTEMS | Warfarin | Hospitalization | Thromboembolism | Patients | Generalized linear models
Journal Article